MondayApr 21, 2008 8:50 am

AVANT Immunotherapeutics, Inc. (AVAN) Surges on Pfizer Agreement

Avant Immunotherapeutics(AVAN:NASDAQ) discovers and develops innovative vaccines and targeted immunotherapeutics for the treatment of cancer and infectious and inflammatory diseases. On March 7th ,the company announced a completed merger with Celldex Therapeutics. The resultant merged company has three commercialized products and a deep pipeline of six products in the development stage. On Thursday April 17th, shares of Avant surged after the company announced a licensing and development agreement with Pfizer. Pfizer will be granted an exclusive worldwide license to a cancer vaccine candidate, CDX-110. This vaccine is in Phase 2 development for the treatment of glioblastoma multiforme which is the…

Continue Reading

MondayApr 21, 2008 8:48 am

Purple Beverage Company, Inc. (PPBV.OB) Adds a Pro to the Marketing Team

Marc de Grandpre, former Managing Director of the New York Red Bulls®, has accepted an offer to join the Purple Beverage Company’s marketing team in his new role as Vice President of Marketing alongside two other former Red Bull team members; Dan Morelli, former director of sales for Red Bull® North America, Inc., and Keith Riley, former national director of on-premise for Red Bull® North America, Inc. Mr. deGrandpre’s career spans many years, including directing East Coast marketing for the team’s parent company, Red Bull® North America, where he elevated the unit from third to first place in sales volume…

Continue Reading

MondayApr 21, 2008 8:48 am

North Bay Resources Inc. (NBRI.PK) Acquires Coronation Gold-Silver Property

North Bay Resources Inc. announced that it has acquired the Coronation Property near Memphis Creek, 6 kilometres northeast of Slocan in southeastern British Columbia. The property covers 103 acres over several reverted crown grants and includes three past-producing mines; the Colorado, the V&M, and the Senator mines, in addition to the Coronation. Primary mineralization is gold, silver, zinc, and lead. The highest combined historical (post-production) assays are 16.8 g/t gold, 6000 g/t silver, 10.9% zinc, and 1.2% lead. According to BC Assessment Report 18603, the Coronation was reported to have past-production of as much as 13,000 grams per tonne silver…

Continue Reading

MondayApr 21, 2008 8:47 am

Fortune Market Media Inc. (FTMM.PK) Acquires Skee.TV; Recruits World Famous DJ Skee

Diversified media company Fortune Market Media Inc. (Pink Sheets: FTMM) today announced it has initiated the acquisition of Skee.TV, the first daily urban lifestyle show featuring celebrity interviews and music videos, available on most mobile phone providers and free to anyone online. "We are very excited to have Skee.TV in our media arsenal and I plan on giving a lot of energy and effort in putting Skee.TV at the forefront of our properties. This addition gives us access to today's most exciting demographic (18-25). This group stays current on new content and new ways of receiving that content. They are…

Continue Reading

MondayApr 21, 2008 8:38 am

Planet Nutrition Holdings Inc. (PNHL.PK) Reports Record Revenues for its Nutritional Supplements Lines

Finding the right mix of product offerings is usually the biggest hurdle that a small retail operation has to overcome in its journey to profit and success. If the company’s product base is too limited, its customer base may change and move on as tastes change. If the company’s product base is to diversified, it may find a fracturing of the core customer base. If it can blend a diversified product line, however, it will be ready for growth and the possibility of the Holy Grail of retail…the franchise. Planet Nutrition Inc., a retail nutrition chain, offers a full range…

Continue Reading

MondayApr 21, 2008 7:24 am

StockGuru News: Columbia River Resources (CRVR) Subsidiary, Traxxec Ltd, Reports Early Success for New Market Channels

NEWCASTLE UNDER LYME, ENGLAND, April 21 / - Traxxec Ltd, the U.K. subsidiary of Columbia River Resources Inc. , today reports negotiations to supply Glaxo SmithKline and Catalent through its new clinical trials sales division. As reported last week, the company has negotiated a policy with Rexam plc that allows it to sell directly in to the pharmaceutical clinical trial arena and to pharmaceutical contract and clinical research organisations. Catalent and Glaxo SmithKline represent two of the biggest names in the contract and pharma arena, ideal customers for the new division. In addition, Traxxec is in talks with a French-based…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered